Zoey Becker

Fierce Pharma

J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses

By: Zoey Becker

Johnson & Johnson and Bayer’s wide spanning VOVAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD).

Fierce Pharma

Catalent aims to push through COVID slog with gene therapy, GLP-1 hype

By: Zoey Becker

Like many other COVID-19 players, CDMO Catalent has been feeling the heat of plunging COVID product demand.

Fierce Pharma

Eli Lilly takes manufacturing push to Germany with plans for large new plant: Reuters

By: Zoey Becker

As demand soars for Eli Lilly's diabetes and obesity newcomers Mounjaro and Zepbound, the company has spent the past year pouring billions into its manufacturing operations.

Fierce Pharma

CDC rushes extra doses of Sanofi, AZ's Beyfortus to ease supply shortfall

By: Zoey Becker

In response to a supply squeeze for Sanofi and AstraZeneca's respiratory syncytial virus (RSV) antibody Beyfortus, the U.S.

Fierce Pharma

Amid ADHD drug shortage, industry group points a finger at government manufacturing restrictions: report

By: Zoey Becker

After many months of shortages affecting attention-deficit/hyperactivity disorder (ADHD) drugs, it was hoped that new generics to Takeda’s Vyvanse would ease the supply situation.

Fierce Pharma

Teva granted pretrial appeal in high-stakes Copaxone kickbacks case

By: Zoey Becker

Teva's latest play in its yearslong defense against kickback claims levied by the U.S. government has secured the company a slight legal reprieve.

Fierce Pharma

Moderna loses a COVID vaccine patent in Europe amid heated clash with BioNTech, Pfizer

By: Zoey Becker

With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war.

Fierce Pharma

Pfizer's cost-savings mission continues with office shuffle, job cuts in Ireland

By: Zoey Becker

Pfizer, working through a $3.5 billion cost-cutting drive, is not done yet making changes to its workforce in Ireland.

Fierce Pharma

Novartis pulls 2 batches of Sandimmune after spotting crystal formations—again

By: Zoey Becker

After pulling one lot of Sandimmune in September due to the unexpected formation of crystals in some bottles, Novartis is once again recalling two batches of the drug.

Fierce Pharma

Teva drops patent case against Lilly after two Ajovy patents deemed invalid

By: Zoey Becker

It's the end of the road for one of Teva's patent lawsuits against migraine competitor Eli Lilly.